| Digital droplet PCR for rapid quantification of donor DNA in the circulation of transplant recipients as a potential universal biomarker of graft injury J Beck, S Bierau, S Balzer, R Andag, P Kanzow, J Schmitz, J Gaedcke, ... Clinical chemistry 59 (12), 1732-1741, 2013 | 336 | 2013 |
| Integration of metabolomics and transcriptomics revealed a fatty acid network exerting growth inhibitory effects in human pancreatic cancer G Zhang, P He, H Tan, A Budhu, J Gaedcke, BM Ghadimi, T Ried, ... Clinical cancer research 19 (18), 4983-4993, 2013 | 275 | 2013 |
| A novel MIF signaling pathway drives the malignant character of pancreatic cancer by targeting NR3C2 S Yang, P He, J Wang, A Schetter, W Tang, N Funamizu, K Yanaga, ... Cancer research 76 (13), 3838-3850, 2016 | 260 | 2016 |
| Impact of RNA degradation on gene expression profiling L Opitz, G Salinas-Riester, M Grade, K Jung, P Jo, G Emons, BM Ghadimi, ... BMC medical genomics 3, 1-14, 2010 | 247 | 2010 |
| DPEP1 inhibits tumor cell invasiveness, enhances chemosensitivity and predicts clinical outcome in pancreatic ductal adenocarcinoma G Zhang, A Schetter, P He, N Funamizu, J Gaedcke, BM Ghadimi, T Ried, ... PloS one 7 (2), e31507, 2012 | 228 | 2012 |
| The mesopancreas is the primary site for R1 resection in pancreatic head cancer: relevance for clinical trials J Gaedcke, B Gunawan, M Grade, R Szöke, T Liersch, H Becker, ... Langenbeck's archives of surgery 395, 451-458, 2010 | 217 | 2010 |
| Mutated KRAS results in overexpression of DUSP4, a MAP‐kinase phosphatase, and SMYD3, a histone methyltransferase, in rectal carcinomas J Gaedcke, M Grade, K Jung, J Camps, P Jo, G Emons, A Gehoff, U Sax, ... Genes, chromosomes and cancer 49 (11), 1024-1034, 2010 | 216 | 2010 |
| The rectal cancer microRNAome–microRNA expression in rectal cancer and matched normal mucosa J Gaedcke, M Grade, J Camps, R Søkilde, B Kaczkowski, AJ Schetter, ... Clinical cancer research 18 (18), 4919-4930, 2012 | 209 | 2012 |
| Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for patients with locally advanced rectal cancer: long-term results of the CAO/ARO … E Fokas, A Schlenska-Lange, B Polat, G Klautke, GG Grabenbauer, ... JAMA oncology 8 (1), e215445-e215445, 2022 | 173 | 2022 |
| Predominance of the basal type and HER-2/neu type in brain metastasis from breast cancer J Gaedcke, F Traub, S Milde, L Wilkens, A Stan, H Ostertag, M Christgen, ... Modern pathology 20 (8), 864-870, 2007 | 168 | 2007 |
| Loss of ATM accelerates pancreatic cancer formation and epithelial–mesenchymal transition R Russell, L Perkhofer, S Liebau, Q Lin, A Lechel, FM Feld, E Hessmann, ... Nature communications 6 (1), 7677, 2015 | 149 | 2015 |
| CA19-9 for detecting recurrence of pancreatic cancer A Azizian, F Rühlmann, T Krause, M Bernhardt, P Jo, A König, M Kleiß, ... Scientific reports 10 (1), 1332, 2020 | 146 | 2020 |
| Phosphoglycerate kinase 1 a promoting enzyme for peritoneal dissemination in gastric cancer D Zieker, I Königsrainer, I Tritschler, M Löffler, S Beckert, F Traub, ... International Journal of Cancer 126 (6), 1513-1520, 2010 | 143 | 2010 |
| Inflammatory fibroblasts mediate resistance to neoadjuvant therapy in rectal cancer AM Nicolas, M Pesic, E Engel, PK Ziegler, M Diefenhardt, KB Kennel, ... Cancer Cell 40 (2), 168-184. e13, 2022 | 141 | 2022 |
| STAT3 inhibition sensitizes colorectal cancer to chemoradiotherapy in vitro and in vivo M Spitzner, B Roesler, C Bielfeld, G Emons, J Gaedcke, HA Wolff, ... International journal of cancer 134 (4), 997-1007, 2014 | 140 | 2014 |
| Macrophage migration inhibitory factor induces epithelial to mesenchymal transition, enhances tumor aggressiveness and predicts clinical outcome in resected pancreatic ductal … N Funamizu, C Hu, C Lacy, A Schetter, G Zhang, P He, J Gaedcke, ... International journal of cancer 132 (4), 785-794, 2013 | 138 | 2013 |
| Chemoradiotherapy resistance in colorectal cancer cells is mediated by Wnt/β-catenin signaling G Emons, M Spitzner, S Reineke, J Möller, N Auslander, F Kramer, Y Hu, ... Molecular Cancer Research 15 (11), 1481-1490, 2017 | 130 | 2017 |
| Silencing of the Wnt transcription factor TCF4 sensitizes colorectal cancer cells to (chemo-) radiotherapy E Kendziorra, K Ahlborn, M Spitzner, M Rave-Fränk, G Emons, J Gaedcke, ... Carcinogenesis 32 (12), 1824-1831, 2011 | 125 | 2011 |
| Antithetical NFAT c1–Sox2 and p53–miR200 signaling networks govern pancreatic cancer cell plasticity SK Singh, NM Chen, E Hessmann, J Siveke, M Lahmann, G Singh, ... The EMBO journal 34 (4), 517-530, 2015 | 111 | 2015 |
| KRAS and BRAF mutations in patients with rectal cancer treated with preoperative chemoradiotherapy J Gaedcke, M Grade, K Jung, M Schirmer, P Jo, C Obermeyer, HA Wolff, ... Radiotherapy and Oncology 94 (1), 76-81, 2010 | 110 | 2010 |
